Navigation Links
Genomas to Present at Life Sciences & Healthcare Venture Summit
Date:10/29/2008

HARTFORD, Conn., Oct. 29 /PRNewswire/ -- Genomas(R) today announced that Gualberto Ruano, MD, PhD, President and CEO, will present at the Life Sciences & Healthcare Venture Summit in New York City on October 30, 2008 at 11:40 a.m. ET. Dr. Ruano's presentation, Bringing DNA-Guided Medicine to the Clinic, will include a corporate overview and an update on the Company's programs in cardiovascular medicine (statins) and psychiatry (atypical antipsychotics).

The Life Sciences & Healthcare Venture Summit connects emerging biotech, pharmaceutical, healthcare, medical device and diagnostic companies with venture capitalists, angel investors and corporate venture capital. Genomas is one of 40 companies selected to present at the 2008 conference.

ABOUT GENOMAS

Genomas(R) Inc. is a biomedical company advancing DNA-guided medicine and personalized healthcare. The company develops revolutionary PhyzioType(TM) Systems for DNA-guided diagnosis and prevention of metabolic disorders induced by drugs in cardiovascular and psychiatric medicine. PhyzioType Systems are designed to provide physicians with an unprecedented capability to select for each patient the safest drug treatment to enhance compliance. Genomas is located in Hartford, CT on the campus of Hartford Hospital. Please visit http://www.genomas.net for more information.


'/>"/>
SOURCE Genomas
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
2. Genomas Awarded $1.2 Million NIH SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy
3. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
6. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
7. Novavax CEO to Present at BIO Investor Forum 2008
8. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
9. Peptimmune Presentations at Upcoming Events
10. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
11. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
Breaking Biology News(10 mins):